跳至主要内容
临床试验/CTRI/2025/07/090805
CTRI/2025/07/090805尚未招募不适用

Evaluation of Comparative efficacy of Continuous vs. Stepwise Implementation Approaches for 12 -Month Lifestyle Medicine Interventions among Polycystic Ovarian Syndrome Patients: A Multicentric Randomized Controlled Trial

ICMR6 个研究点 分布在 1 个国家目标入组 612 人开始时间: 2025年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
ICMR
入组人数
612
试验地点
6
主要终点
To compare the effect of continuous Vs stepwise lifestyle medicine interventions over 12 months in terms of improving PCOS

研究概览

简要总结

Polycystic Ovarian Syndrome (PCOS) is a commonly observed endocrine disease in women of reproductive age. Disrupted hormonal balance and metabolic disturbances distinguish it. Although Lifestyle Medicine (LM)  therapies are commonly advised for the treatment of PCOS, there is a scarcity of research that compares the outcomes between continuous and stepwise implementation approaches. LM is a medical specialty that uses therapeutic LM as a primary modality to treat chronic conditions. Applying the six pillars of LM, viz., whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances, and positive social connections, provides effective prevention for these conditions.

The originality of this study is to assess the effectiveness and practicality of continuous implementation compared to stepwise implementation of LM therapies in enhancing health outcomes and quality of life among patients with PCOS. Addressing all six domains of LM at the initial stage of treatment can present challenges. It could result in a less positive reaction to the treatment. Our hypothesis suggests that implementing targeted domain treatment in a 2-1-2-1 format could potentially enhance the efficacy of the treatment.

The study aims to enlist individuals with PCOS from various centers and allocate them randomly to either the continuous or stepwise implementation groups. Here, a randomized controller trial for 12 months will assess hormonal profiles, polycystic ovarian morphology, menstrual regularity, metabolic parameters, and physical fitness, stress, circadian rhythm,sleep, diet, addiction, social connections, and quality of life among PCOS patients.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Participants who will provide informed consent& available for follow-up assessments indicating their willingness to participate in the research study, including undergoing randomization to either the continuous or stepwise implementation group.
  • Subjects having diagnosis of PCOS based on modified Rotterdam criteria
  • Patients taking following standard of care treatment for PCOS a.
  • Hormonal Treatment (Oral Contraceptive) 30 mcg Ethinyl Estradiol + 150 mcg Levonorgestrel, Once daily (for 21 days followed by 7-day break) b.
  • Insulin-Sensitizing Agent Metformin, 1000 mg, Twice daily Myoinositol, 1000 mg, Once daily.

排除标准

  • 1.Participants who are currently pregnant & breastfeeding, as breastfeeding can also impact hormonal levels and may interfere with the interventions or assessments.
  • 2.Participants with severe medical conditions which include uncontrolled diabetes, , severe mental health disorders.
  • 3.Participants with hyperprolactinemia and thyroid abnormality 4.Participants taking medicines as antipsychotics drugs, antidepressants drugs.
  • 5.Presence of other causes of androgen excess and anovulatory infertility, such as: Congenital adrenal hyperplasia, Cushing syndrome, Androgen-secreting tumors 6.History of bariatric surgery or planning to undergo other weight loss strategies during the study period.
  • 7.Women with lower limb pathology or any condition that precludes participation in physical activity.

结局指标

主要结局

To compare the effect of continuous Vs stepwise lifestyle medicine interventions over 12 months in terms of improving PCOS

时间窗: Baseline, every 15 days for first 2 months, followed by every month till 12 months

Assessments: Ovarian volume, Menstrual cycle history, Polycystic Ovarian morphology, hormonal and biochemical assay, dietary assessment etc.

时间窗: Baseline, every 15 days for first 2 months, followed by every month till 12 months

次要结局

  • NA(NA)

研究者

发起方
ICMR
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Raj Kumar Yadav

All India Institute of Medical Sciences, New Delhi

研究点 (6)

Loading locations...

相似试验

Investigating the Effectiveness of Continuous vs... | 临床试验